Records containing: Psoriasis Vulgaris
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2025-02-24ClinicalTrials.gov study NCT01837576
-
CLINICAL_TRIALS study record update · 2025-02-24Dermatopharmacokinetic Trial of LEO 80185 Gel
-
CLINICAL_TRIALS study record update · 2025-02-24Calcipotriol Plus Betamethasone Dipropionate Gel Compared to Betamethasone Dipropionate in the Gel Vehicle, Calcipotriol in the Gel Vehicle and the Gel Vehicle Alone in Psoriasis Vulgaris
-
CLINICAL_TRIALS study record update · 2025-02-24Skin Irritation Trial of LEO 90100 Foam (Calcipotriol Hydrate Plus Betamethasone Dipropionate) in Healthy Japanese Subjects
-
CLINICAL_TRIALS study record update · 2025-02-24An Exploratory Psoriasis Plaque Test Trial Investigating the Neurogenic Component in Psoriasis Vulgaris by Use of Botulinum Toxin A as Tool Compound
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2025-02-24A Psoriasis Plaque Test on LEO 27989 Ointment and Calcipotriol Plus LEO 27989 Ointment in Patients With Psoriasis Vulgaris.
-
CLINICAL_TRIALS study record update · 2025-02-24A Phase I Exploratory Study Evaluating 3 Formulations of LEO 29102 Plus Calcipotriol, Ointment, LEO 29102 Ointment, Calcipotriol Ointment, Daivonex® Ointment and Diprosone® Ointment in the Treatment of Psoriasis
-
CLINICAL_TRIALS study record update · 2025-02-24ClinicalTrials.gov study NCT01105286
-
CLINICAL_TRIALS study record update · 2025-02-24A Phase 2 Maximal Use Systemic Exposure Study Evaluating the Safety and Efficacy of Calcipotriol 50 mcg/g Plus Betamethasone 0.5 mg/g (as Dipropionate) Gel Applied Once Daily in Subjects With Extensive Psoriasis Vulgaris on the Scalp and Non-scalp Regions of the Body (Trunk and/or Limbs)
-
CLINICAL_TRIALS study record update · 2025-02-24Combined Cumulative Irritation Potential and Repeat Insult Patch Test of LEO 90100
-
CLINICAL_TRIALS study record update · 2025-02-24A Randomised, Double-blind, Active-controlled, Parallel, Multi-center Study to Investigate the Efficacy and Safety of Daivobet® Ointment in Patients With Psoriasis Vulgaris
-
CLINICAL_TRIALS study record update · 2025-02-24LEO 22811 - A Phase I, Double-Blind, Placebo-controlled, Single and Multiple Oral Dose, Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Study in Healthy Subjects
-
CLINICAL_TRIALS study record update · 2025-02-24ClinicalTrials.gov study NCT01946386
-
CLINICAL_TRIALS study record update · 2025-02-24ClinicalTrials.gov study NCT02533973
-
CLINICAL_TRIALS study record update · 2025-02-24Different Treatment Regimens of Calcipotriol Cream and Combination (Calcipotriol/Betamethasone Dipropionate) Ointment in Psoriasis Vulgaris
-
CLINICAL_TRIALS study record update · 2025-01-22A Preliminary Study on the Effect of Photothermal Laser Therapy on the Vascularization and Innervation of Psoriatic Lesions
-
CLINICAL_TRIALS study record update · 2024-10-26A Phase 1b, Randomised, Controlled, Observer-blinded Trial to Assess Safety, Tolerability and Pharmacodynamic Effects of LEO 134310 Cutaneous Solution in Descaled Skin of Adults With Chronic Plaque Psoriasis
-
CLINICAL_TRIALS study record update · 2024-09-19Modified Intermittent Fasting in Psoriasis Trial: a Randomized Controlled Open Crossover Clinical Trial to Investigate the Effects of a Dietary Intervention on the Gut-skin Axis in Patients with Psoriasis
-
CLINICAL_TRIALS study record update · 2024-09-19A Non-inferiority Study on Dose Reduction of Adalimumab in Psoriasis Patients
-
CLINICAL_TRIALS study record update · 2024-09-19Evaluation of the Preditive Value of Early Serum Trough Concentrations and Anti-drug Antibodies of Guselkumab and the Development of the Concentration-response Curve of Guselkumab for Psoriasis Patients.
-
CLINICAL_TRIALS study record update · 2024-09-19Evaluation of the Predictive Value of Early Serum Trough Concentrations and Anti-drug Antibodies of Brodalumab and the Development of Concentration-response Curve of Brodalumab of Psoriasis Patients.
-
CLINICAL_TRIALS study record update · 2024-09-19Evaluation of the Predictive Value of Early Serum Trough Concentrations and Anti-drug Antibodies of Secukinumab and the Development of a Concentration Response Curve of Secukinumab for Psoriasis Patients.
-
CLINICAL_TRIALS study record update · 2024-09-19Evaluation of the Predictive Value of Early Serum Trough Concentrations and Anti-drug Antibodies of Ixekizumab and the Development of Concentration-response Curve of Ixekizumab for Psoriasis Patients
-
CLINICAL_TRIALS study record update · 2024-09-19Exploratory Study to Evaluate the Safety and Efficacy of CD10367 in Subjects With Psoriasis
-
CLINICAL_TRIALS study record update · 2024-08-21Frequency of Tuberculosis in Psoriasis Patients Using Anti-TNF Therapy During 15 Years of Follow-up.